AREC

Arecor Therapeutics (AREC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AREC
DataOraFonteTitoloSimboloCompagnia
03/05/202419:02Alliance NewsAlliance NewsIN BRIEF: Arecor Therapeutics delays publication of 2023 resultsLSE:ARECArecor Therapeutics Plc
03/05/202417:44RNS Regulatory NewsArecor Therapeutics PLC Publication of Full Year Financial Results delayedLSE:ARECArecor Therapeutics Plc
29/04/202408:00RNS Regulatory NewsArecor Therapeutics PLC Notice of resultsLSE:ARECArecor Therapeutics Plc
23/04/202412:02Alliance NewsAlliance NewsArecor chief financial officer to leave in July after five yearsLSE:ARECArecor Therapeutics Plc
23/04/202408:00RNS Regulatory NewsArecor Therapeutics PLC BOARD CHANGELSE:ARECArecor Therapeutics Plc
12/03/202413:16Alliance NewsAlliance NewsArecor to develop "holy grail" diabetes treatment with partner TRxLSE:ARECArecor Therapeutics Plc
12/03/202409:58RNS Regulatory NewsArecor Therapeutics PLC Arecor and TRx Biosciences research collaborationLSE:ARECArecor Therapeutics Plc
29/02/202420:42Alliance NewsAlliance NewsEARNINGS AND TRADING: East Star, Getech strike Kazakhstan JVLSE:ARECArecor Therapeutics Plc
29/02/202408:00RNS Regulatory NewsArecor Therapeutics PLC Arecor announces launch of Ogluo® in NetherlandsLSE:ARECArecor Therapeutics Plc
01/02/202415:24Alliance NewsAlliance NewsArecor Therapeutics hails Arestat as 2023 performance "strong"LSE:ARECArecor Therapeutics Plc
01/02/202408:00RNS Regulatory NewsArecor Therapeutics PLC Year End Trading UpdateLSE:ARECArecor Therapeutics Plc
23/01/202422:47Alliance NewsAlliance NewsIN BRIEF: Arecor pleased as investee Inhibrx sells therapy to SanofiLSE:ARECArecor Therapeutics Plc
23/01/202417:58UK RegulatoryArecor Therapeutics PLC Arecor announces update on INBRX-101LSE:ARECArecor Therapeutics Plc
18/01/202419:26Alliance NewsAlliance NewsTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsLSE:ARECArecor Therapeutics Plc
18/01/202408:00UK RegulatoryArecor Therapeutics PLC Arecor granted key European patentLSE:ARECArecor Therapeutics Plc
08/01/202412:34Alliance NewsAlliance NewsArecor expands speciality hospital collaboration with partnerLSE:ARECArecor Therapeutics Plc
08/01/202408:00UK RegulatoryArecor Therapeutics PLC Expansion of specialty hospital collaborationLSE:ARECArecor Therapeutics Plc
03/01/202408:00UK RegulatoryArecor Therapeutics PLC Appointment of SVP for Tetris Pharma LtdLSE:ARECArecor Therapeutics Plc
04/12/202316:42Alliance NewsAlliance NewsArecor inks co-development deal with global medical companyLSE:ARECArecor Therapeutics Plc
04/12/202308:00UK RegulatoryArecor Therapeutics PLC Agreement with global medical products companyLSE:ARECArecor Therapeutics Plc
29/11/202315:28Alliance NewsAlliance NewsTRADING UPDATES: Arecor inks Eli Lilly deal; RBG appoints McNair CFOLSE:ARECArecor Therapeutics Plc
29/11/202308:00UK RegulatoryArecor Therapeutics PLC Arecor Continues Collaboration with LillyLSE:ARECArecor Therapeutics Plc
17/11/202312:45Alliance NewsAlliance NewsIN BRIEF: Arecor Therapeutics gets "milestone payment" from AT220 saleLSE:ARECArecor Therapeutics Plc
17/11/202308:00UK RegulatoryArecor Therapeutics PLC Product with Arestat technology launched in EuropeLSE:ARECArecor Therapeutics Plc
02/11/202322:01Alliance NewsAlliance NewsTRADING UPDATES: Troy Income suspends buyback of sharesLSE:ARECArecor Therapeutics Plc
02/11/202308:00UK RegulatoryArecor Therapeutics PLC Inhibrx milestone triggers payment to ArecorLSE:ARECArecor Therapeutics Plc
01/11/202316:31UK RegulatoryArecor Therapeutics PLC Exercise of rollover options & Total Voting RightsLSE:ARECArecor Therapeutics Plc
02/10/202312:11Alliance NewsAlliance NewsArecor Therapeutics ups subject numbers for insulin-focused trialLSE:ARECArecor Therapeutics Plc
02/10/202308:00UK RegulatoryArecor Therapeutics PLC Progress of Phase I clinical study of AT278LSE:ARECArecor Therapeutics Plc
15/09/202308:00RNS Non-RegulatoryArecor Therapeutics PLC Arecor on Investor Meet Company PlatformLSE:ARECArecor Therapeutics Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AREC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network